PAXIL
LOE Approachingparoxetine hydrochloride
NDAORALTABLET
Approved
Dec 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
18
Mechanism of Action
12.1 Mechanism of Action The mechanism of action of PAXIL in the treatment of MDD, SAD, OCD, PD, GAD, and PTSD is unknown, but is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from inhibition of neuronal reuptake of serotonin…
Indications (1)
Clinical Trials (5)
Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants
Started Dec 2020
38 enrolled
Anxiety Disorders
Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
Started Jan 2010
600 enrolled
Social Phobia
Paxil CR Bioequivalence Study Brazil - Fed Administration
Started Oct 2009
60 enrolled
Depressive Disorder
Paxil CR Bioequivalence Study Brazil
Started Sep 2009
60 enrolled
Depressive Disorder
Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
Started Mar 2009
56 enrolled
Depressive Disorder